Actively Recruiting
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-04-22
20
Participants Needed
7
Research Sites
257 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to see whether 68Gallium PSMA-PET/CT scans are an effective way to detect sites of cancer in people with metastatic bladder cancer or skin cancer. The study researchers want to learn if a 68Gallium PSMA PET/CT scan will work better, the same, or not as well as the PET/CT scans doctors usually use for imaging bladder cancer or skin cancer (FDG-PET/CT scan).
CONDITIONS
Official Title
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years or older
- For urothelial carcinoma: confirmed metastatic urothelial carcinoma with extrapelvic nodal and/or visceral disease sites
- At least one lesion assessable by FDG PET/CT suspicious for metastasis
- Karnofsky performance status 50% or higher (or ECOG/WHO 2 or lower)
- For melanoma: confirmed metastatic melanoma
- At least one metastatic lesion assessable by CT or FDG PET/CT suspicious for metastasis
- ECOG performance status 2 or lower
- Ability to understand and sign informed consent
You will not qualify if you...
- For urothelial carcinoma: only pelvic lymph node metastatic disease without nodes outside pelvis
- Bone only metastatic disease
- Unable to lie flat, stay still, or tolerate PET scan
- Active treatment for non-urothelial malignancy except non-metastatic skin basal cell or superficial squamous cell carcinoma
- Participation in therapeutic clinical trial that interferes with PSMA imaging
- Active surveillance for non-urothelial malignancies
- Pregnant women or women of childbearing potential without negative pregnancy test
- For melanoma: unable to lie flat, stay still, or tolerate PET scan
- Participation in therapeutic trial interfering with PSMA imaging
- Pregnant women or women of childbearing potential without negative pregnancy test
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Memorial Sloan Kettering Basking Ridge (Consent Only)
Basking Ridge, New Jersey, United States, 10065
Actively Recruiting
2
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown, New Jersey, United States, 07748
Actively Recruiting
3
Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale, New Jersey, United States, 07645
Actively Recruiting
4
Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
Commack, New York, United States, 11725
Actively Recruiting
5
Memorial Sloan Kettering West Harrison (All Protocol Activities)
Harrison, New York, United States, 10604
Actively Recruiting
6
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States, 10065
Actively Recruiting
7
Memorial Sloan Kettering Nassau (All Protocol Activities)
Uniondale, New York, United States, 11553
Actively Recruiting
Research Team
G
Gopakumar Iyer, MD
CONTACT
A
Alexander Shoushtari, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here